Literature DB >> 31591481

Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1.

Ying Ying1, Yejun Wang1, Xiaoyan Huang1, Yanmei Sun1, Junbao Zhang1, Meiqi Li1, Junhui Zeng1, Maolin Wang1, Wenjun Xiao1, Lan Zhong2, Bo Xu3, Lili Li4, Qian Tao4, Xiaomei Wang1, Xing-Sheng Shu5.   

Abstract

Aberrant activation of Homeobox genes in human cancers has long been documented, whereas the mechanisms underlying remain largely obscure. Super-enhancers (SEs) act as key regulatory elements for both cell identity genes and cancer genes. Herein, we reported that SE-associated HOXB gene cluster represented a common feature of colorectal cancer (CRC) cell lines and multiple HOXB genes within this cluster were overexpressed in CRC. Among them, we found that HOXB8 was oncogenic and its activation in CRC was driven by SE instead of genetic alteration. We further demonstrated that the master transcription factor MYC preferentially occupied SEs over TEs (typical enhancers) and regulated HOXB8 transcription by binding to the active elements of its SE. HOXB8 silencing induced reversal of transcriptional signatures associated with malignant phenotypes of CRC. Mechanistically, HOXB8 interacted with a key metastasis regulator BACH1 and instigated BACH1-mediated transcriptional cascade by directly occupying and activating BACH1 gene transcription together with BACH1 itself. Lastly, the relevance of HOXB8 activation in clinical settings was strengthened by its close association with prognostic outcomes of CRC patients.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31591481     DOI: 10.1038/s41388-019-1013-1

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  44 in total

Review 1.  Super-Enhancer-Driven Transcriptional Dependencies in Cancer.

Authors:  Satyaki Sengupta; Rani E George
Journal:  Trends Cancer       Date:  2017-04-12

2.  Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.

Authors:  Marc R Mansour; Brian J Abraham; Lars Anders; Alla Berezovskaya; Alejandro Gutierrez; Adam D Durbin; Julia Etchin; Lee Lawton; Stephen E Sallan; Lewis B Silverman; Mignon L Loh; Stephen P Hunger; Takaomi Sanda; Richard A Young; A Thomas Look
Journal:  Science       Date:  2014-11-13       Impact factor: 47.728

3.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

Review 4.  Transcriptional enhancers: from properties to genome-wide predictions.

Authors:  Daria Shlyueva; Gerald Stampfel; Alexander Stark
Journal:  Nat Rev Genet       Date:  2014-03-11       Impact factor: 53.242

5.  Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.

Authors:  Liangru Ke; Hufeng Zhou; Chong Wang; Geng Xiong; Yanqun Xiang; Yihong Ling; Abdelmajid Khabir; George S Tsao; Yixin Zeng; Musheng Zeng; Pierre Busson; Elliott Kieff; Xiang Guo; Bo Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-22       Impact factor: 11.205

6.  Epigenomic enhancer profiling defines a signature of colon cancer.

Authors:  Batool Akhtar-Zaidi; Richard Cowper-Sal-lari; Olivia Corradin; Alina Saiakhova; Cynthia F Bartels; Dheepa Balasubramanian; Lois Myeroff; James Lutterbaugh; Awad Jarrar; Matthew F Kalady; Joseph Willis; Jason H Moore; Paul J Tesar; Thomas Laframboise; Sanford Markowitz; Mathieu Lupien; Peter C Scacheri
Journal:  Science       Date:  2012-04-12       Impact factor: 47.728

7.  Master transcription factors and mediator establish super-enhancers at key cell identity genes.

Authors:  Warren A Whyte; David A Orlando; Denes Hnisz; Brian J Abraham; Charles Y Lin; Michael H Kagey; Peter B Rahl; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 8.  The role of enhancers in cancer.

Authors:  Inderpreet Sur; Jussi Taipale
Journal:  Nat Rev Cancer       Date:  2016-07-01       Impact factor: 60.716

9.  Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.

Authors:  Xiaoyang Zhang; Peter S Choi; Joshua M Francis; Marcin Imielinski; Hideo Watanabe; Andrew D Cherniack; Matthew Meyerson
Journal:  Nat Genet       Date:  2015-12-14       Impact factor: 38.330

10.  Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor.

Authors:  Xiaoyang Zhang; Peter S Choi; Joshua M Francis; Galen F Gao; Joshua D Campbell; Aruna Ramachandran; Yoichiro Mitsuishi; Gavin Ha; Juliann Shih; Francisca Vazquez; Aviad Tsherniak; Alison M Taylor; Jin Zhou; Zhong Wu; Ashton C Berger; Marios Giannakis; William C Hahn; Andrew D Cherniack; Matthew Meyerson
Journal:  Cancer Discov       Date:  2017-09-29       Impact factor: 39.397

View more
  17 in total

1.  The roles of HOXB8 through activating Wnt/β-catenin and STAT3 signaling pathways in the growth, migration and invasion of ovarian cancer cells.

Authors:  Lidan Liu; Lifei Wang; Xiujuan Li
Journal:  Cytotechnology       Date:  2022-01-03       Impact factor: 2.058

Review 2.  Significant position of C-myc in colorectal cancer: a promising therapeutic target.

Authors:  Li Tan; Dong Peng; Yong Cheng
Journal:  Clin Transl Oncol       Date:  2022-08-16       Impact factor: 3.340

3.  Zinc finger protein 280C contributes to colorectal tumorigenesis by maintaining epigenetic repression at H3K27me3-marked loci.

Authors:  Ying Ying; Maolin Wang; Yongheng Chen; Meiqi Li; Canjie Ma; Junbao Zhang; Xiaoyan Huang; Min Jia; Junhui Zeng; Yejun Wang; Lili Li; Xiaomei Wang; Qian Tao; Xing-Sheng Shu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-23       Impact factor: 12.779

4.  Downregulation of long non-coding RNA MAFG-AS1 represses tumorigenesis of colorectal cancer cells through the microRNA-149-3p-dependent inhibition of HOXB8.

Authors:  Zhiyan Ruan; Hongling Deng; Minhua Liang; Zhe Xu; Manxiang Lai; Hong Ren; Xiangliang Deng; Xinguo Su
Journal:  Cancer Cell Int       Date:  2020-10-19       Impact factor: 5.722

5.  Functional Interrogation of Enhancer Connectome Prioritizes Candidate Target Genes at Ovarian Cancer Susceptibility Loci.

Authors:  Wei Wang; Fengju Song; Xiangling Feng; Xinlei Chu; Hongji Dai; Jing Tian; Xuan Fang; Fangfang Song; Ben Liu; Lian Li; Xiangchun Li; Yanrui Zhao; Hong Zheng; Kexin Chen
Journal:  Front Genet       Date:  2021-03-19       Impact factor: 4.599

6.  Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2.

Authors:  Meng Xie; Mengyu Sun; Xiaoyu Ji; Dongxiao Li; Xiaoping Chen; Bixiang Zhang; Wenjie Huang; Tongyue Zhang; Yijun Wang; Dean Tian; Limin Xia
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

Review 7.  Molecular implications of HOX genes targeting multiple signaling pathways in cancer.

Authors:  U Sangeetha Shenoy; Divya Adiga; Shama Prasada Kabekkodu; Keith D Hunter; Raghu Radhakrishnan
Journal:  Cell Biol Toxicol       Date:  2021-10-06       Impact factor: 6.691

Review 8.  RSF1 in cancer: interactions and functions.

Authors:  Guiyang Cai; Qing Yang; Wei Sun
Journal:  Cancer Cell Int       Date:  2021-06-19       Impact factor: 5.722

9.  Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer.

Authors:  Junbao Zhang; Ying Ying; Meiqi Li; Maolin Wang; Xiaoyan Huang; Min Jia; Junhui Zeng; Canjie Ma; Yixiang Zhang; Chen Li; Xiaomei Wang; Xing-Sheng Shu
Journal:  Theranostics       Date:  2020-08-08       Impact factor: 11.556

10.  A Systematic Review on HOX Genes as Potential Biomarkers in Colorectal Cancer: An Emerging Role of HOXB9.

Authors:  Eirini Martinou; Giulia Falgari; Izhar Bagwan; Angeliki M Angelidi
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.